Cargando…
Discovery of a highly potent and selective Bruton’s tyrosine kinase inhibitor avoiding impairment of ADCC effects for B-cell non-Hodgkin lymphoma
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7490411/ https://www.ncbi.nlm.nih.gov/pubmed/32929063 http://dx.doi.org/10.1038/s41392-020-00309-1 |
| _version_ | 1783582035685670912 |
|---|---|
| author | Liu, Juan Liang, Qianmao Wang, Aoli Zou, Fengming Qi, Ziping Yu, Kailin Liu, Qingwang Chen, Cheng Liu, Jing Liu, Qingsong |
| author_facet | Liu, Juan Liang, Qianmao Wang, Aoli Zou, Fengming Qi, Ziping Yu, Kailin Liu, Qingwang Chen, Cheng Liu, Jing Liu, Qingsong |
| author_sort | Liu, Juan |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7490411 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | Nature Publishing Group UK |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-74904112020-10-01 Discovery of a highly potent and selective Bruton’s tyrosine kinase inhibitor avoiding impairment of ADCC effects for B-cell non-Hodgkin lymphoma Liu, Juan Liang, Qianmao Wang, Aoli Zou, Fengming Qi, Ziping Yu, Kailin Liu, Qingwang Chen, Cheng Liu, Jing Liu, Qingsong Signal Transduct Target Ther Letter Nature Publishing Group UK 2020-09-14 /pmc/articles/PMC7490411/ /pubmed/32929063 http://dx.doi.org/10.1038/s41392-020-00309-1 Text en © The Author(s) 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
| spellingShingle | Letter Liu, Juan Liang, Qianmao Wang, Aoli Zou, Fengming Qi, Ziping Yu, Kailin Liu, Qingwang Chen, Cheng Liu, Jing Liu, Qingsong Discovery of a highly potent and selective Bruton’s tyrosine kinase inhibitor avoiding impairment of ADCC effects for B-cell non-Hodgkin lymphoma |
| title | Discovery of a highly potent and selective Bruton’s tyrosine kinase inhibitor avoiding impairment of ADCC effects for B-cell non-Hodgkin lymphoma |
| title_full | Discovery of a highly potent and selective Bruton’s tyrosine kinase inhibitor avoiding impairment of ADCC effects for B-cell non-Hodgkin lymphoma |
| title_fullStr | Discovery of a highly potent and selective Bruton’s tyrosine kinase inhibitor avoiding impairment of ADCC effects for B-cell non-Hodgkin lymphoma |
| title_full_unstemmed | Discovery of a highly potent and selective Bruton’s tyrosine kinase inhibitor avoiding impairment of ADCC effects for B-cell non-Hodgkin lymphoma |
| title_short | Discovery of a highly potent and selective Bruton’s tyrosine kinase inhibitor avoiding impairment of ADCC effects for B-cell non-Hodgkin lymphoma |
| title_sort | discovery of a highly potent and selective bruton’s tyrosine kinase inhibitor avoiding impairment of adcc effects for b-cell non-hodgkin lymphoma |
| topic | Letter |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7490411/ https://www.ncbi.nlm.nih.gov/pubmed/32929063 http://dx.doi.org/10.1038/s41392-020-00309-1 |
| work_keys_str_mv | AT liujuan discoveryofahighlypotentandselectivebrutonstyrosinekinaseinhibitoravoidingimpairmentofadcceffectsforbcellnonhodgkinlymphoma AT liangqianmao discoveryofahighlypotentandselectivebrutonstyrosinekinaseinhibitoravoidingimpairmentofadcceffectsforbcellnonhodgkinlymphoma AT wangaoli discoveryofahighlypotentandselectivebrutonstyrosinekinaseinhibitoravoidingimpairmentofadcceffectsforbcellnonhodgkinlymphoma AT zoufengming discoveryofahighlypotentandselectivebrutonstyrosinekinaseinhibitoravoidingimpairmentofadcceffectsforbcellnonhodgkinlymphoma AT qiziping discoveryofahighlypotentandselectivebrutonstyrosinekinaseinhibitoravoidingimpairmentofadcceffectsforbcellnonhodgkinlymphoma AT yukailin discoveryofahighlypotentandselectivebrutonstyrosinekinaseinhibitoravoidingimpairmentofadcceffectsforbcellnonhodgkinlymphoma AT liuqingwang discoveryofahighlypotentandselectivebrutonstyrosinekinaseinhibitoravoidingimpairmentofadcceffectsforbcellnonhodgkinlymphoma AT chencheng discoveryofahighlypotentandselectivebrutonstyrosinekinaseinhibitoravoidingimpairmentofadcceffectsforbcellnonhodgkinlymphoma AT liujing discoveryofahighlypotentandselectivebrutonstyrosinekinaseinhibitoravoidingimpairmentofadcceffectsforbcellnonhodgkinlymphoma AT liuqingsong discoveryofahighlypotentandselectivebrutonstyrosinekinaseinhibitoravoidingimpairmentofadcceffectsforbcellnonhodgkinlymphoma |